ADAM8 and breast carcinoma: Lately, the metalloprotease disintegrin ADAM8 has been characterized in the association with PSGL-1 shedding (Domínguez-Luis et al., 2011) and the spread of breast cancer cells (Romagnoli et al., 2014).